AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Opranis D 30mg/20mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Avtix Health (India) Private Limited

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Opranis D 30mg/20mg Tablet SR

Gastro-esophageal reflux disease (GERD), or acid reflux, can be managed with Opranis D 30mg/20mg SR tablets, a dual-action medication. This formulation alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion, thus easing discomfort. Opranis D should be taken on an empty stomach, following your physician's prescribed dosage and regimen. Treatment duration depends on individual response and the severity of your condition; premature discontinuation may lead to symptom recurrence and disease exacerbation. Always inform your doctor about all other medications you are using, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects promptly. Drowsiness and dizziness are potential effects; avoid driving or activities requiring alertness until you assess your response. Alcohol consumption should be limited as it may intensify drowsiness. Dietary changes, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, may enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy planning, or breastfeeding to your healthcare provider.

Uses of Opranis D 30mg/20mg Tablet SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Opranis D 30mg/20mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Opranis D 30mg/20mg Tablet SR whole; do not chew, crush, or divide it. Administer on an empty stomach.

Common Side effects of Opranis D 30mg/20mg Tablet SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Opranis D 30mg/20mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Opranis D 30mg/20mg Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.

How Opranis D 30mg/20mg Tablet SR works:

Opranis D SR, a 30mg/20mg tablet, unites Domperidone and Rabeprazole to address digestive issues. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Opranis D 30mg/20mg SR tablets with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Opranis D 30mg/20mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Opranis D 30mg/20mg tablets are likely unsafe for breastfeeding mothers. Available human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking Opranis D 30mg/20mg SR tablets, as this medication may impair alertness and coordination.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Opranis D 30mg/20mg sustained-release tablets. Dosage modification of Opranis D 30mg/20mg sustained-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use the 30mg/20mg sustained-release Opranis D tablet cautiously, potentially requiring dose modification. Medical advice is recommended. Opranis D 30mg/20mg sustained-release tablets are unsuitable for individuals with moderate-to-severe hepatic dysfunction.

What if you forget to take Opranis D 30mg/20mg Tablet SR :

Should you forget to take your Opranis D 30mg/20mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Opranis D 30mg/20mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Gastrointestinal system

FAQs on Opranis D 30mg/20mg Tablet SR

Opranis D 30mg/20mg sustained-release tablets contain domperidone and rabeprazole. This dual medication addresses heartburn, acid reflux (GERD), where stomach acid enters the esophagus, and also manages gastric and duodenal ulcers. Domperidone's action enhances gut motility, facilitating smoother food passage through the stomach and thus alleviating nausea.
Opranis D 30mg/20mg sustained-release tablets are contraindicated in individuals exhibiting hypersensitivity to rabeprazole, domperidone, or any excipients within the formulation. Patients with pre-existing hepatic or renal impairment require careful monitoring during treatment.
Indeed, Opranis D 30mg/20mg SR tablets may lead to xerostomia. This side effect is attributed to the domperidone component. To alleviate dry mouth, increase your fluid intake. Keep water readily available, especially overnight. Reduce alcohol consumption and refrain from smoking. Should dry mouth persist, opt for an alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Opranis D 30mg/20mg Tablet SR. If diarrhea occurs, increase your fluid intake. Refrain from consuming greasy or deep-fried foods while taking this medication. Consult your physician if diarrhea continues or if you observe dehydration symptoms such as reduced urination and dark, strongly-scented urine.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure its inaccessibility to children, pets, and others.
Opranis D 30mg/20mg sustained-release tablets are generally well-tolerated. Nevertheless, some individuals may experience typical side effects including diarrhea, abdominal pain, gas, dry mouth, lightheadedness, and headache. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
For optimal absorption, consume Opranis D 30mg/20mg sustained-release tablets before your initial meal or while fasting.
Taking Opranis D 30mg/20mg Tablet SR may raise the likelihood of an abnormal heart rhythm (a serious arrhythmia). While this is a significant potential side effect, the probability of occurrence remains quite small. However, the risk might be marginally greater for individuals over 60.
Opranis D 30mg/20mg sustained-release tablets contain domperidone and rabeprazole. This formulation addresses heartburn, acidity, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for gastric and duodenal ulcers. Domperidone's action facilitates improved gut motility, easing food passage through the stomach and managing vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any inactive components of Opranis D 30mg/20mg Tablet SR should avoid its use. Individuals with pre-existing kidney or liver conditions require careful monitoring when considering this medication.
Indeed, taking Opranis D 30mg/20mg sustained-release tablets may result in xerostomia. This side effect is attributed to the domperidone component. To alleviate dry mouth, increase your fluid intake. Maintain a water source by your bed overnight. Reduce alcohol consumption and abstain from smoking. For dry mouth, utilize alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a possible side effect of Opranis D 30mg/20mg Tablet SR. If diarrhea occurs, increase fluid intake. Refrain from consuming greasy or deep-fried foods while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strongly-scented urine, appear.
Opranis D 30mg/20mg sustained-release tablets are generally well-tolerated. Nevertheless, some individuals may experience common adverse reactions including diarrhea, abdominal discomfort, flatulence, dry mouth, vertigo, and cephalalgia, along with less frequent or infrequent side effects. Report any ongoing issues to your physician during treatment.
For optimal absorption, consume Opranis D 30mg/20mg sustained-release tablets prior to your initial meal or while fasting.
Taking Opranis D 30mg/20mg Tablet SR may raise the likelihood of an abnormal heart rhythm (severe arrhythmias). While this is a serious potential adverse effect, the probability is quite small. However, the risk might be somewhat elevated for individuals over 60.
Maintain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Opranis D 30mg/20mg Table...
56
MRP 68
17% off